Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALT Altimmune, Inc.

交易中 07-15 13:41:07 EDT

4.24

-0.02

-0.59%

最高4.29	最低4.13	成交量155.28万
今开4.29	昨收4.26	日振幅3.87%
总市值3.43亿	流通市值3.41亿	总股本8,111万
成交额649.11万	换手率1.93%	流通股本8,043万
市净率2.42	ROE-57.28%	每股收益-1.25
52周最高11.16	52周最低2.90	市盈率-3.39
股息0.00	股息收益率0.00	ROA-35.51%

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALT","market":"US","secType":"STK","nameCN":"Altimmune, Inc.","latestPrice":4.235,"timestamp":1752601261056,"preClose":4.26,"halted":0,"volume":1552846,"delay":0,"floatShares":80428472,"shares":81106973,"eps":-1.250036,"marketStatus":"交易中","change":-0.025,"latestTime":"07-15 13:41:04 EDT","open":4.29,"high":4.29,"low":4.125,"amount":6491112.902017,"amplitude":0.038732,"askPrice":4.24,"askSize":2265,"bidPrice":4.23,"bidSize":3731,"shortable":3,"etf":0,"ttmEps":-1.250036,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752609600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":4.26,"preHourTrading":{"tag":"盘前","latestPrice":4.208,"preClose":4.26,"latestTime":"09:29 EDT","volume":28869,"amount":123125.649882,"timestamp":1752586172489},"postHourTrading":{"tag":"盘后","latestPrice":4.2001,"preClose":4.26,"latestTime":"19:59 EDT","volume":73513,"amount":312363.63,"timestamp":1752537590651},"volumeRatio":0.503944,"impliedVol":0.8522,"impliedVolPercentile":0.056},"requestUrl":"/m/hq/s/ALT","defaultTab":"news","newsList":[{"id":"2550856957","title":"Altimmune, Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550856957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550856957?lang=zh_cn&edition=full","pubTime":"2025-07-11 23:25","pubTimestamp":1752247540,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日23时25分，Altimmune, Inc.股票出现波动，股价急速跳水5.00%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.76%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。消息层面，截至23时25分，《Citizens JMP维持Altimmune买入评级，下调目标价至15美元》资讯为影响Altimmune, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711232540953ef103&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711232540953ef103&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4139","ALT","LU1878469433.USD"],"gpt_icon":0},{"id":"2550162527","title":"Altimmune, Inc.盘中异动 股价大跌14.98%报4.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550162527","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550162527?lang=zh_cn&edition=full","pubTime":"2025-07-10 21:32","pubTimestamp":1752154326,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日21时32分，Altimmune, Inc.股票出现波动，股价急速下挫14.98%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。消息层面，截至21时32分，《Citizens JMP维持Altimmune买入评级，下调目标价至15美元》资讯为影响Altimmune, Inc.的重要信息。根据TipRanks数据显示，该分析师近一年总胜率为45.1%，总平均回报率为8.3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213206a442b7ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213206a442b7ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","LU1878469433.USD","BK4139","BK4599"],"gpt_icon":0},{"id":"2549558823","title":"Altimmune, Inc.盘中异动 早盘急速下挫5.04%报4.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549558823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549558823?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:34","pubTimestamp":1751895281,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时34分，Altimmune, Inc.股票出现波动，股价急速跳水5.04%。截至发稿，该股报4.52美元/股，成交量40.0072万股，换手率0.49%，振幅3.57%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213441979d183f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213441979d183f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","BK4599","ALT","BK4139"],"gpt_icon":0},{"id":"2547097800","title":"Altimmune, Inc.盘中异动 早盘急速下挫5.14%报3.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547097800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547097800?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:38","pubTimestamp":1751290731,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时38分，Altimmune, Inc.股票出现波动，股价快速跳水5.14%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 涨幅较大，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃，换手率分别为2139.23%、124.12%、70.55%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Galectin Therapeutics Inc.、Cognition Therapeutics, Inc.，振幅分别为131.52%、111.02%、109.17%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213851a4c6c7d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213851a4c6c7d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","ALT","BK4139","BK4599"],"gpt_icon":0},{"id":"2546726615","title":"Altimmune, Inc.盘中异动 下午盘股价大跌5.26%报3.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546726615","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546726615?lang=zh_cn&edition=full","pubTime":"2025-06-28 03:01","pubTimestamp":1751050873,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日03时01分，Altimmune, Inc.股票出现波动，股价大幅下跌5.26%。截至发稿，该股报3.42美元/股，成交量1455.8万股，换手率17.95%，振幅9.14%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506280301139791b878&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506280301139791b878&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1878469433.USD","ALT","BK4599"],"gpt_icon":0},{"id":"2546713920","title":"速递｜一夜股价腰斩！Altimmune GLP-1新药疗效令投资人失望","url":"https://stock-news.laohu8.com/highlight/detail?id=2546713920","media":"GLP1减重宝典","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546713920?lang=zh_cn&edition=full","pubTime":"2025-06-27 16:36","pubTimestamp":1751013387,"startTime":"0","endTime":"0","summary":"整理 | GLP1减重宝典内容团队Altimmune, Inc.公司今日公布了其候选药物pemvidutide在代谢相关脂肪性肝炎治疗中IMPACT 2b期临床试验的积极初步结果。然而，其疗效令投资人失望，股价一夜之间腰斩。治疗期间的退出率较低，仅9%的受试者提前终止治疗。治疗组在ELF和VCTE等非侵入性纤维化评估及ALT炎症指标方面均显著优于安慰剂。因不良反应停药率在两个治疗组中分别为0.0%和1.2%，安慰剂组为2.4%。未报告与研究药物相关的严重不良事件或心律失常。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627165430a720734f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627165430a720734f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","BK4139","GLP","BK4599","LU1878469433.USD","BK4590","BK4144"],"gpt_icon":1},{"id":"1104040108","title":"异动解读 | Altimmune股价暴跌61.61%，肥胖症药物临床试验数据令市场失望","url":"https://stock-news.laohu8.com/highlight/detail?id=1104040108","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104040108?lang=zh_cn&edition=full","pubTime":"2025-06-26 21:33","pubTimestamp":1750944789,"startTime":"0","endTime":"0","summary":"生物制药公司Altimmune, Inc.今日盘中大跌61.61%，引发市场广泛关注。这一剧烈波动与该公司最新公布的临床试验结果密切相关。Altimmune周四发布了其用于治疗肥胖症的实验性药物培美度肽的中期试验结果。结果显示，在212名患者参与的试验中，59.1%的参与者的MASH症状有所缓解，且肝脏瘢痕没有恶化。此外，试验中患者的体重平均减轻了6.2%。然而，尽管达到了部分试验目标，但投资者对结果似乎并不满意。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ALT"],"gpt_icon":0},{"id":"1163001551","title":"异动解读 | Altimmune股价盘前暴跌61.48%，肝纤维化改善数据不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1163001551","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163001551?lang=zh_cn&edition=full","pubTime":"2025-06-26 20:24","pubTimestamp":1750940664,"startTime":"0","endTime":"0","summary":"生物制药公司Altimmune, Inc.今日盘前股价大幅下挫，跌幅高达61.48%，引起市场广泛关注。这一剧烈波动与该公司最新公布的临床试验结果密切相关。此外，试验中患者的体重平均减轻了6.2%。然而，尽管达到了主要试验目标，但投资者对结果似乎并不满意。这可能是导致股价大跌的主要原因。目前，pemvidutide作为一种肥胖症治疗药物正在单独进行研究，市场将密切关注其后续发展。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"异动解读 | Altimmune股价盘前暴跌61.48%，肝纤维化改善数据不及预期","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ALT"],"gpt_icon":1},{"id":"2546223905","title":"Altimmune, Inc.盘中异动 临近收盘大幅上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546223905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546223905?lang=zh_cn&edition=full","pubTime":"2025-06-26 03:30","pubTimestamp":1750879833,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日03时30分，Altimmune, Inc.股票出现波动，股价大幅拉升5.00%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，Vor Biopharma Inc.、Plus Therapeutics, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Seastar Medical Holding Corporation、Plus Therapeutics, Inc.、Aditxt, Inc.较为活跃，换手率分别为2403.49%、1364.09%、848.45%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Vor Biopharma Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为159.26%、112.42%、88.27%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626033034a71d89d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626033034a71d89d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","BK4599","BK4139","ALT"],"gpt_icon":0},{"id":"2545678172","title":"Altimmune, Inc.盘中异动 下午盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545678172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545678172?lang=zh_cn&edition=full","pubTime":"2025-06-21 02:19","pubTimestamp":1750443594,"startTime":"0","endTime":"0","summary":"北京时间2025年06月21日02时19分，Altimmune, Inc.股票出现异动，股价快速上涨5.09%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Processa Pharmaceuticals, Inc.涨幅较大，Nucana Plc、Processa Pharmaceuticals, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为1643.15%、1137.12%、427.06%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Galectin Therapeutics Inc.、Seastar Medical Holding Corporation，振幅分别为65.00%、62.42%、52.25%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621021955978844e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621021955978844e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1878469433.USD","ALT","BK4599"],"gpt_icon":0},{"id":"2543820606","title":"Altimmune, Inc.盘中异动 早盘股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543820606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543820606?lang=zh_cn&edition=full","pubTime":"2025-06-16 21:49","pubTimestamp":1750081772,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日21时49分，Altimmune, Inc.股票出现波动，股价快速拉升5.20%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Sage Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Immuneering Corporation涨幅较大，Nucana Plc、Processa Pharmaceuticals, Inc.、Pmgc Holdings Inc.较为活跃，换手率分别为1542.24%、189.48%、37.01%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Nextcure, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为36.10%、32.11%、30.36%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616214932951ec769&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616214932951ec769&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","BK4139","LU1878469433.USD","BK4599"],"gpt_icon":0},{"id":"2543634922","title":"Altimmune, Inc.盘中异动 下午盘股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543634922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543634922?lang=zh_cn&edition=full","pubTime":"2025-06-14 02:31","pubTimestamp":1749839501,"startTime":"0","endTime":"0","summary":"北京时间2025年06月14日02时31分，Altimmune, Inc.股票出现波动，股价大幅下跌5.16%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.78%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614023141a7080d5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614023141a7080d5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","BK4599","BK4139","LU1878469433.USD"],"gpt_icon":0},{"id":"2543546533","title":"Altimmune, Inc.盘中异动 快速上涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543546533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543546533?lang=zh_cn&edition=full","pubTime":"2025-06-13 00:21","pubTimestamp":1749745265,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日00时21分，Altimmune, Inc.股票出现异动，股价大幅上涨5.35%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 、Klotho Neurosciences, Inc.涨幅较大，Nucana Plc、Polyrizon Ltd.、Klotho Neurosciences, Inc.较为活跃，换手率分别为2481.02%、767.83%、305.16%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 、Liminatus Pharma, Inc.，振幅分别为256.24%、169.83%、87.67%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613002105977cdac0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613002105977cdac0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1878469433.USD","ALT","BK4599"],"gpt_icon":0},{"id":"2542582337","title":"Altimmune, Inc.盘中异动 临近收盘大幅上涨5.07%报5.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542582337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542582337?lang=zh_cn&edition=full","pubTime":"2025-06-10 03:48","pubTimestamp":1749498532,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日03时48分，Altimmune, Inc.股票出现异动，股价大幅拉升5.07%。截至发稿，该股报5.91美元/股，成交量200.96万股，换手率2.48%，振幅5.69%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为1.61%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061003485297784303&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061003485297784303&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","LU1878469433.USD","BK4599","BK4139"],"gpt_icon":0},{"id":"2541908866","title":"Altimmune, Inc.盘中异动 股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541908866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541908866?lang=zh_cn&edition=full","pubTime":"2025-06-06 22:40","pubTimestamp":1749220833,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日22时40分，Altimmune, Inc.股票出现波动，股价大幅拉升5.22%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Estrella Immunopharma Inc C/Wts 29/09/2028、Klotho Neurosciences, Inc.涨幅较大，Nucana Plc、Eyenovia, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为2256.45%、719.68%、84.40%，振幅较大的相关个股有Eyenovia, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tango Therapeutics, Inc.，振幅分别为41.40%、34.76%、32.22%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060622403497747f92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060622403497747f92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","LU1878469433.USD","ALT","BK4139"],"gpt_icon":0},{"id":"2540799269","title":"Altimmune, Inc.盘中异动 早盘急速下跌5.16%报5.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540799269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540799269?lang=zh_cn&edition=full","pubTime":"2025-06-02 22:04","pubTimestamp":1748873041,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日22时04分，Altimmune, Inc.股票出现异动，股价快速下挫5.16%。截至发稿，该股报5.15美元/股，成交量47.9556万股，换手率0.59%，振幅6.54%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602220401a496c4a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602220401a496c4a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","BK4599","BK4139","LU1878469433.USD"],"gpt_icon":0},{"id":"2537264778","title":"Altimmune, Inc.盘中异动 下午盘股价大涨5.00%报5.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537264778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537264778?lang=zh_cn&edition=full","pubTime":"2025-05-21 01:52","pubTimestamp":1747763546,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日01时52分，Altimmune, Inc.股票出现波动，股价急速上涨5.00%。截至发稿，该股报5.78美元/股，成交量93.5318万股，换手率1.15%，振幅6.64%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521015226975fc3de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521015226975fc3de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","ALT","BK4599","BK4139"],"gpt_icon":0},{"id":"2536926695","title":"Altimmune, Inc.2025财年第一财季实现净利润-19.58百万美元，同比增加19.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536926695","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536926695?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:01","pubTimestamp":1747584093,"startTime":"0","endTime":"0","summary":"5月19日，Altimmune, Inc.公布财报，公告显示公司2025财年第一财季净利润为-19.58百万美元，同比增加19.72%；其中营业收入为5000.00美元，同比增加0.00%，每股基本收益为-0.26美元。从资产负债表来看，Altimmune, Inc.总负债15.10百万美元，其中短期债务245000.00美元，资产负债比为0.11，流动比率为0.16。机构评级：截至2025年5月19日，当前有8家机构对Altimmune, Inc.目标价做出预测，其中目标均价为22.38美元，其中最低目标价为12.00美元，最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000529a6e3a858&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000529a6e3a858&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT"],"gpt_icon":0},{"id":"2534275253","title":"Altimmune, Inc.盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534275253","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534275253?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:31","pubTimestamp":1747056704,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时31分，Altimmune, Inc.股票出现异动，股价快速上涨5.19%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Cytomx Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Fortrea Holdings Inc.涨幅较大，Nucana Plc、Cytomx Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为283.67%、60.03%、58.48%，振幅较大的相关个股有Athira Pharma, Inc.、Imunon, Inc.、Gri Bio, Inc.，振幅分别为12.86%、10.00%、9.52%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213144a6dc4fce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213144a6dc4fce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","LU1878469433.USD","BK4599","BK4139"],"gpt_icon":0},{"id":"2533195245","title":"Altimmune, Inc.盘中异动 快速拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533195245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533195245?lang=zh_cn&edition=full","pubTime":"2025-05-08 00:41","pubTimestamp":1746636098,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日00时41分，Altimmune, Inc.股票出现异动，股价大幅上涨5.17%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508004139aa2c863b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508004139aa2c863b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","BK4599","ALT","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.altimmune.com","stockEarnings":[{"period":"1week","weight":-0.0384},{"period":"1month","weight":-0.3844},{"period":"3month","weight":-0.0596},{"period":"6month","weight":-0.3526},{"period":"1year","weight":-0.4608},{"period":"ytd","weight":-0.4092}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0466},{"period":"3month","weight":0.1622},{"period":"6month","weight":0.054},{"period":"1year","weight":0.1158},{"period":"ytd","weight":0.0661}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Altimmune, Inc.于2005年4月25日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司，专注于开发肥胖和肝脏疾病的治疗方法。公司的主要候选产品pemvidutide（原名ALT-801）是一种GLP-1/胰高血糖素双受体激动剂，正在开发用于治疗肥胖和代谢功能障碍相关的脂肪性肝炎（“MASH”），以前称为非酒精性脂肪性肝炎（“NASH”）。","yearOnYearQuotes":[{"month":1,"riseRate":0.388889,"avgChangeRate":-0.008115},{"month":2,"riseRate":0.388889,"avgChangeRate":0.000059},{"month":3,"riseRate":0.388889,"avgChangeRate":-0.052418},{"month":4,"riseRate":0.388889,"avgChangeRate":-0.049636},{"month":5,"riseRate":0.5,"avgChangeRate":0.064208},{"month":6,"riseRate":0.388889,"avgChangeRate":-0.000157},{"month":7,"riseRate":0.444444,"avgChangeRate":0.050035},{"month":8,"riseRate":0.411765,"avgChangeRate":0.108003},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.121386},{"month":10,"riseRate":0.222222,"avgChangeRate":0.030284},{"month":11,"riseRate":0.388889,"avgChangeRate":-0.02446},{"month":12,"riseRate":0.555556,"avgChangeRate":0.21194}],"exchange":"NASDAQ","name":"Altimmune, Inc.","nameEN":"Altimmune, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Altimmune, Inc.(ALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Altimmune, Inc.,ALT,Altimmune, Inc.股票,Altimmune, Inc.股票老虎,Altimmune, Inc.股票老虎国际,Altimmune, Inc.行情,Altimmune, Inc.股票行情,Altimmune, Inc.股价,Altimmune, Inc.股市,Altimmune, Inc.股票价格,Altimmune, Inc.股票交易,Altimmune, Inc.股票购买,Altimmune, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Altimmune, Inc.(ALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}